Illustration by Moukkaa

Company Information

As of 10/26/22
Country
U.S.
Headquarters
Somerset, N.J.
Industry
Pharmaceuticals
CEO
Alessandro Maselli
Company Type
Public
Ticker
CTLT
Revenues ($M)
$4,703
Profits ($M)
$513
Market Value ($M)
$13,377
Employees
17,300
Revenue and net income for the four quarters ended on or before April 30, 2022. Market value as of Oct. 17, 2022.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$3,998
29.2%
Profits ($M)
$585
165.1%
Assets ($M)
$9,112
-
Total Stockholder Equity ($M)
$4,274
-

Profit Ratios

Profit as % of Revenues
14.6%
Profits as % of Assets
6.4%
Profits as % of Stockholder Equity
13.7%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
311
EPS % Change (from 2020)
172.8%
EPS % Change (5 year annual rate)
28.4%
EPS % Change (10 year annual rate)
-

Total Return

Total Return to Investors (2021)
23%
Total Return to Investors (5 year, annualized)
36.6%
Total Return to Investors (10 year, annualized)
-

Catalent Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$3,094.322.9%$220.760.6%$7,776.5$3,505.4
2020$2,5182.2%$137.464.4%$6,184$2,288.2
2019$2,463.418.7%$83.6-23.9%$4,531.1$1,086.7
2018$2,075.412.3%$109.8-1.5%$3,454.3$723.5
2017$1,8480.9%$111.5-47.5%$3,091$636
FortuneDataStore ad
Lists ranking Catalent
RANK692
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK60
100 Fastest-Growing Companies - 2022This year’s group delivered stellar revenue and pr...READ MORE